Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

U S Physical Therapy (USPH) Shares Outstanding (2016 - 2025)

U S Physical Therapy's Shares Outstanding history spans 12 years, with the latest figure at $17.2 million for Q3 2023.

  • For Q3 2023, Shares Outstanding rose 13.05% year-over-year to $17.2 million; the TTM value through Sep 2023 reached $17.2 million, up 13.05%, while the annual FY2022 figure was $15.2 million, 0.6% up from the prior year.
  • Shares Outstanding for Q3 2023 was -$2.2 million at U S Physical Therapy, down from $17.2 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $17.2 million in Q2 2023 and bottomed at -$2.2 million in Q1 2019.
  • The 5-year median for Shares Outstanding is -$2.2 million (2019), against an average of $4.3 million.
  • The largest annual shift saw Shares Outstanding plummeted 114.87% in 2019 before it surged 789.71% in 2023.
  • A 5-year view of Shares Outstanding shows it stood at $15.0 million in 2019, then increased by 0.51% to $15.1 million in 2020, then rose by 0.4% to $15.1 million in 2021, then grew by 0.6% to $15.2 million in 2022, then grew by 13.05% to $17.2 million in 2023.
  • Per Business Quant, the three most recent readings for USPH's Shares Outstanding are $17.2 million (Q3 2023), -$2.2 million (Q2 2023), and $15.3 million (Q1 2023).